BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36991081)

  • 1. Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme.
    Erthal LCS; Shi Y; Sweeney KJ; Gobbo OL; Ruiz-Hernandez E
    Sci Rep; 2023 Mar; 13(1):5094. PubMed ID: 36991081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
    Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V
    J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor.
    Kang JH; Turabee MH; Lee DS; Kwon YJ; Ko YT
    Biomed Pharmacother; 2021 Nov; 143():112144. PubMed ID: 34509823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
    Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
    J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loco-regional treatment with temozolomide-loaded thermogels prevents glioblastoma recurrences in orthotopic human xenograft models.
    Gherardini L; Vetri Buratti V; Maturi M; Inzalaco G; Locatelli E; Sambri L; Gargiulo S; Barone V; Bonente D; Bertelli E; Tortorella S; Franci L; Fioravanti A; Comes Franchini M; Chiariello M
    Sci Rep; 2023 Mar; 13(1):4630. PubMed ID: 36944737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy.
    Sandbhor P; Goda JS; Mohanty B; Chaudhari P; Dutt S; Banerjee R
    Nanoscale; 2022 Sep; 14(35):12773-12788. PubMed ID: 36001382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-sensitive drug-loaded hydrogel system for local inhibition of post-surgical glioma recurrence.
    Chen S; Qiu Q; Wang D; She D; Yin B; Gu G; Chai M; Heo DN; He H; Wang J
    J Control Release; 2022 Sep; 349():565-579. PubMed ID: 35835399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible copolymer formulations to treat glioblastoma multiforme.
    Erthal LCS; Gobbo OL; Ruiz-Hernandez E
    Acta Biomater; 2021 Feb; 121():89-102. PubMed ID: 33227487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.
    Lukács G; Tóth Z; Sipos D; Csima M; Hadjiev J; Bajzik G; Cselik Z; Semjén D; Repa I; Kovács Á
    Ideggyogy Sz; 2018 Mar; 71(3-04):95-103. PubMed ID: 29889468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.
    Huang J; Chaudhary R; Cohen AL; Fink K; Goldlust S; Boockvar J; Chinnaiyan P; Wan L; Marcus S; Campian JL
    J Neurooncol; 2019 May; 142(3):537-544. PubMed ID: 30771200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrative and Sustained Drug Delivery Using Injectable Hydrogel Nanocomposites for Postsurgical Brain Tumor Treatment.
    Kang T; Cha GD; Park OK; Cho HR; Kim M; Lee J; Kim D; Lee B; Chu J; Koo S; Hyeon T; Kim DH; Choi SH
    ACS Nano; 2023 Mar; 17(6):5435-5447. PubMed ID: 36926815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy.
    Ding L; Wang Q; Shen M; Sun Y; Zhang X; Huang C; Chen J; Li R; Duan Y
    Autophagy; 2017 Jul; 13(7):1176-1190. PubMed ID: 28594260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conformal hydrogel nanocomposite for local delivery of paclitaxel.
    Tao J; Zhang J; Hu Y; Yang Y; Gou Z; Du T; Mao J; Gou M
    J Biomater Sci Polym Ed; 2017 Jan; 28(1):107-118. PubMed ID: 27765001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme.
    Jatyan R; Singh P; Sahel DK; Karthik YG; Mittal A; Chitkara D
    J Control Release; 2022 Oct; 350():494-513. PubMed ID: 35985493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
    Banstola A; Duwa R; Emami F; Jeong JH; Yook S
    Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.